Spots Global Cancer Trial Database for colorectal cancer liver metastases
Every month we try and update this database with for colorectal cancer liver metastases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Aspirin in Colorectal Cancer Liver Metastases | NCT03326791 | Colorectal Canc... Colorectal Canc... Liver Metastase... | Acetylsalicylic... Placebo Oral Ta... | 18 Years - | Oslo University Hospital | |
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM | NCT05485909 | Colorectal Canc... | Radiofrequency ... Regorafenib and... | 18 Years - | Sun Yat-sen University | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE | NCT04272931 | Colorectal Canc... | Portal and Hepa... | 18 Years - | Maastricht University | |
Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases | NCT05588297 | Colorectal Canc... | CapOx(Capecitab... Bevacizumab Nivolumab | 18 Years - 75 Years | Shanghai Changzheng Hospital | |
Oslo Randomized Laparoscopic Versus Open Liver Resection for Colorectal Metastases Study | NCT01516710 | Secondary Malig... Colorectal Neop... | Open liver rese... Laparoscopic li... | 18 Years - | Oslo University Hospital | |
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases | NCT05794971 | Colorectal Canc... Regorafenib | Regorafenib and... Regorafenib | 18 Years - 70 Years | Sun Yat-sen University | |
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | NCT02208804 | Colorectal Neop... Neoplasm Metast... Liver Diseases Digestive Syste... | Holmium-166-pol... | 18 Years - | UMC Utrecht | |
Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases | NCT05794971 | Colorectal Canc... Regorafenib | Regorafenib and... Regorafenib | 18 Years - 70 Years | Sun Yat-sen University | |
PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES | NCT02086656 | Colorectal Canc... | capecitabine, o... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |